Related Experiment Video
Updated: Aug 15, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Cancer chemoprevention: scientific promise, clinical uncertainty
Michael B Sporn1, Karen T Liby
1Department of Pharmacology, Dartmouth Medical School, Hanover, NH 03755, USA. michael.b.sporn@dartmouth.edu
Abstract:
We review fundamental processes, such as mutation, oxidative stress, and inflammation that are critical for carcinogenesis and provide specific molecular targets for new chemopreventive agents. New information from molecular biology studies has identified such targets, including regulatory molecules such as Nrf2 (nuclear factor erythroid 2-related factor 2), epidermal growth factor receptor kinases, phosphatidylinositol 3-kinase, components of the Janus kinase-signal transducers and activators of transcription (JAK-STAT) pathway, nuclear factor-kappaB, and cyclin D. The development of new drugs for the control of these targets that are both safe and effective will be important for the future of cancer chemoprevention.
Insights
This review highlights key molecular targets, including Nrf2 and JAK-STAT, involved in cancer development. Identifying and targeting these molecules is crucial for developing effective new cancer chemoprevention strategies.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Carcinogenesis involves fundamental processes like mutation, oxidative stress, and inflammation.
- Molecular biology advances have revealed critical molecular targets within these processes.
Purpose of the Study:
- To review fundamental processes critical for carcinogenesis.
- To identify specific molecular targets for novel chemopreventive agents.
Main Methods:
- Literature review of molecular biology studies.
- Analysis of regulatory molecules implicated in cancer development.
Main Results:
- Identified key molecular targets including Nrf2 (nuclear factor erythroid 2-related factor 2), epidermal growth factor receptor kinases, phosphatidylinositol 3-kinase, JAK-STAT pathway components, nuclear factor-kappaB, and cyclin D.
- These targets play crucial roles in carcinogenesis.
Conclusions:
- Development of safe and effective drugs targeting these identified molecules is essential for future cancer chemoprevention.
- Targeting specific molecular pathways offers a promising avenue for cancer prevention.
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Some...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
